AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36086061 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using signals from a wrist wearable device
Number of subjects: 0
Study 33242697 — intervention group
Group type: COMPARATOR
Intervention: Omalizumab
Number of subjects: 0
Study 32533792 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac (COX2-inhibitor) administered for 20 perioperative days, starting 5 days before surgery.
Number of subjects: 34
Study 32533792 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (control).
Number of subjects: 34
Study 32533792 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac (treatment group).
Number of subjects: 34
Study 32533792 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac (treatment group, protocol-compliant patients).
Number of subjects: 34
Study 32533792 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (control, protocol-compliant patients).
Number of subjects: 34
Study 35768774 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (treadmill running at 15-20 m/min for 60 min, 5 days/week for 5 weeks)
Number of subjects: 0
Study 35768774 — intervention group
Group type: COMPARATOR
Intervention: Sedentary (control group)
Number of subjects: 0
Study 33831649 — intervention group
Group type: COMPARATOR
Intervention: Electronic seizure diary (e-diary)
Number of subjects: 66
Study 35946217 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Q
Number of subjects: 91
Study 35946217 — intervention group
Group type: COMPARATOR
Intervention: ILMA
Number of subjects: 91
Study 33543655 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (18 mg/day) from 1 week before until 1 month after adjuvant radiotherapy
Number of subjects: 74
Study 33543655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 33024339 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary training with reminder (text message)
Number of subjects: 320
Study 33024339 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance learning with reminder (text message)
Number of subjects: 320
Study 33024339 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary training
Number of subjects: 320
Study 33024339 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance learning
Number of subjects: 320
Study 36282988 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 51
Study 36282988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 34446682 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive interventions in occupational health (OH)
Number of subjects: 3428
Study 34446682 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs) of preventive interventions
Number of subjects: 3428
Study 34446682 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic reviews of preventive interventions
Number of subjects: 3428
Study 32092084 — intervention group
Group type: EXPERIMENTAL
Intervention: Op-Ed article about political probity
Number of subjects: 0
Study 32092084 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34491543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrite infusion for 1 hour
Number of subjects: 33
Study 34491543 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion for 1 hour
Number of subjects: 33
Study 35317772 — intervention group
Group type: EXPERIMENTAL
Intervention: AFFIRM intervention (awareness of reduced fetal movements and care pathway)
Number of subjects: 0
Study 35317772 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 35010998 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroberberine 100 mg (D100)
Number of subjects: 5
Study 35010998 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroberberine 200 mg (D200)
Number of subjects: 5
Study 35010998 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine 500 mg (B500)
Number of subjects: 5
Study 35010998 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 5
Study 36379612 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage regional citrate anticoagulation (RCA) with 0.04 g/mL sodium citrate infusion for 3 hours during dialysis
Number of subjects: 159
Study 36379612 — intervention group
Group type: COMPARATOR
Intervention: Saline flushing
Number of subjects: 159
Study 36379612 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage regional citrate anticoagulation (RCA)
Number of subjects: 159
Study 32484415 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiphase Menon score
Number of subjects: 119
Study 32484415 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-phase Menon score
Number of subjects: 119
Study 32484415 — intervention group
Group type: COMPARATOR
Intervention: CT perfusion parameters
Number of subjects: 119
Study 35182393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Cognitive Therapy (MBCT)
Number of subjects: 89
Study 35182393 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused Attention (FA)
Number of subjects: 89
Study 35182393 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Monitoring (OM)
Number of subjects: 89
Study 32656770 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (awareness of diagnostic label)
Number of subjects: 120
Study 32656770 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-awareness of label)
Number of subjects: 120
Study 33413942 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chloride (CaCl2) injection (2 ml of 5%) into the major atrial ganglionated plexi during CABG
Number of subjects: 200
Study 33413942 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (0.9%) injection (sham control) into the major atrial ganglionated plexi during CABG
Number of subjects: 200
Study 33413942 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chloride (CaCl2) injection
Number of subjects: 200
Study 34545949 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 33623076 — intervention group
Group type: EXPERIMENTAL
Intervention: nabiximols
Number of subjects: 27
Study 33623076 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study 33465767 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) supplementation
Number of subjects: 5544
Study 35125737 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Postplacental (PP) group
Number of subjects: 0
Study 35125737 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Postabortal (PA) group
Number of subjects: 0
Study 35125737 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval (INT) group
Number of subjects: 0
Study 35125737 — intervention group
Group type: COMPARATOR
Intervention: Cumulative expulsion
Number of subjects: 0
Study 35125737 — intervention group
Group type: COMPARATOR
Intervention: Cumulative removal
Number of subjects: 0
Study 32369571 — intervention group
Group type: EXPERIMENTAL
Intervention: Encode protocol
Number of subjects: 47
Study 32369571 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 47
Study 32001517 — intervention group
Group type: EXPERIMENTAL
Intervention: TennisReady (e-health prevention programme)
Number of subjects: 579
Study 32001517 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 579
Study 32001517 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherent group
Number of subjects: 579
Study 32001517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low adherent group
Number of subjects: 579
Study 32483061 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (twice-weekly for 6 weeks)
Number of subjects: 20
Study 32483061 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard in-season regimen)
Number of subjects: 20
Study 33057936 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mmHg pneumoperitoneum
Number of subjects: 201
Study 33057936 — intervention group
Group type: COMPARATOR
Intervention: 12 mmHg pneumoperitoneum
Number of subjects: 201
Study 32460786 — intervention group
Group type: EXPERIMENTAL
Intervention: ARCHES intervention (treatment condition)
Number of subjects: 0
Study 32460786 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care contraceptive counseling (control condition)
Number of subjects: 0
Study 35502575 — intervention group
Group type: EXPERIMENTAL
Intervention: Pridinol (PRI)
Number of subjects: 342
Study 35502575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study 34092636 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transcranial photobiomodulation (c-tPBM) with near-infrared radiation (830 nm; 54.8 mW/cm2; 65.8 J/cm2; 2.3 kJ)
Number of subjects: 10
Study 34092636 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial photobiomodulation (s-tPBM)
Number of subjects: 10
Study 32384205 — intervention group
Group type: EXPERIMENTAL
Intervention: 577-nm high-power optically pumped semiconductor laser (HOPSL) treatment
Number of subjects: 21
Study 32384205 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 21
Study 83186811 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconditioning aversion program with vodka
Number of subjects: 47
Study 83186811 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconditioning aversion program with preferred beverage
Number of subjects: 47
Study 83186811 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconditioning aversion program with both shock and covert sensitization
Number of subjects: 47
Study 83186811 — intervention group
Group type: EXPERIMENTAL
Intervention: Internals and hard liquor drinkers
Number of subjects: 47
Study 83186811 — intervention group
Group type: EXPERIMENTAL
Intervention: Field dependency
Number of subjects: 47
Study 83186811 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-preferred beverage
Number of subjects: 47
Study 34268566 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based resistance exercises co-designed by group discussion contributors (mean age 75, 61% female)
Number of subjects: 112
Study 34268566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary guidance and patient communication co-designed in workshops (mean age 71, 60% females)
Number of subjects: 112
Study 34268566 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty intervention format and GP follow-up shaped in telephone interviews (mean age 77, 63% female)
Number of subjects: 112
Study 34032204 — intervention group
Group type: COMPARATOR
Intervention: Daclatasvir hydrochloride tablets (60 mg) under fasting conditions
Number of subjects: 72
Study 34032204 — intervention group
Group type: COMPARATOR
Intervention: Daclatasvir hydrochloride tablets (60 mg) under postprandial conditions
Number of subjects: 72
Study 36207891 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 29
Study 36207891 — intervention group
Group type: COMPARATOR
Intervention: Rope-skipping exercise (RS)
Number of subjects: 29
Study 36207891 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction combined with rope-skipping exercise (CR-RS)
Number of subjects: 29
Study 36207891 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (CT)
Number of subjects: 29
Study 33536253 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 70
Study 33536253 — intervention group
Group type: COMPARATOR
Intervention: Intensive insulin only (Control)
Number of subjects: 70
Study 33485162 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity clinical simulation
Number of subjects: 0
Study 33485162 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study 35690997 — intervention group
Group type: EXPERIMENTAL
Intervention: AH8 10% lotion formulated in Cetaphil Moisturizing Facial Lotion
Number of subjects: 0
Study 35690997 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.00005% AH8
Number of subjects: 0
Study 35690997 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0005% AH8
Number of subjects: 0
Study 35690997 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% AH8
Number of subjects: 0
Study 35690997 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% AH8
Number of subjects: 0
Study 33667308 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Nitrous oxide (N2O)
Number of subjects: 80
Study 33667308 — intervention group
Group type: COMPARATOR
Intervention: Medical air
Number of subjects: 80
Study 35001901 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 0
Study 35001901 — intervention group
Group type: COMPARATOR
Intervention: Non-rebreather mask (NRBM)
Number of subjects: 0
Study 34099004 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated implementation (external facilitation)
Number of subjects: 25
Study 34099004 — intervention group
Group type: COMPARATOR
Intervention: Minimal implementation support
Number of subjects: 25
Study 36437993 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic intervention for 3 months
Number of subjects: 0
Study 36437993 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 0
Study 34655393 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar vessel sealing system
Number of subjects: 68
Study 34655393 — intervention group
Group type: COMPARATOR
Intervention: Silk ligation of lymphatic vessels
Number of subjects: 68
Study 35643956 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 83295
Study 35643956 — intervention group
Group type: COMPARATOR
Intervention: TNFi
Number of subjects: 83295
Study 35643956 — intervention group
Group type: COMPARATOR
Intervention: ORAL Surveillance trial
Number of subjects: 83295
Study 33881472 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic nigerosylnigerose (CNN)
Number of subjects: 13
Study 33881472 — intervention group
Group type: COMPARATOR
Intervention: Fructooligosaccharide (FOS)
Number of subjects: 13
Study 32130716 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of municipal water
Number of subjects: 140
Study 32130716 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with someone with acute gastroenteritis
Number of subjects: 140
Study 32130716 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with a child in daycare
Number of subjects: 140
Study 32130716 — intervention group
Group type: EXPERIMENTAL
Intervention: Being less than 35 years of age
Number of subjects: 140
Study 32130716 — intervention group
Group type: COMPARATOR
Intervention: Drinking water from a private artesian well
Number of subjects: 140
Study 34878695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (CBI)
Number of subjects: 92
Study 34878695 — intervention group
Group type: COMPARATOR
Intervention: Supportive Intervention (SI)
Number of subjects: 92
Study 33932799 — intervention group
Group type: EXPERIMENTAL
Intervention: LSFD + DP
Number of subjects: 62
Study 33932799 — intervention group
Group type: COMPARATOR
Intervention: LSFD
Number of subjects: 62
Study 32655950 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 22
Study 32655950 — intervention group
Group type: COMPARATOR
Intervention: NIV-PSV
Number of subjects: 22
Study 36300839 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 1267
Study 36300839 — intervention group
Group type: COMPARATOR
Intervention: Commercial Program 12 weeks (CP12)
Number of subjects: 1267
Study 36300839 — intervention group
Group type: COMPARATOR
Intervention: Commercial Program 52 weeks (CP52)
Number of subjects: 1267
Study 34483329 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm ergometer exercise in hot and humid environment (60% peak power output for 60 min)
Number of subjects: 18
Study 34347775 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodemographic predictors (female sex, higher education)
Number of subjects: 133
Study 34347775 — intervention group
Group type: EXPERIMENTAL
Intervention: Flight-related predicting factors (variability of traumatic events)
Number of subjects: 133
Study 34347775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health stigma
Number of subjects: 133
Study 34347775 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-migration factors (low income, lack of social support, low life satisfaction, strong connection to Syria)
Number of subjects: 133
Study 34347775 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatization
Number of subjects: 133
Study 32665999 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 58
Study 32665999 — intervention group
Group type: COMPARATOR
Intervention: Alpha-adrenoreceptor blocker only (Control)
Number of subjects: 58
Study 35366393 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined social communication therapy at home and in education
Number of subjects: 0
Study 35366393 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32508977 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable infusion needles with a separation‐free safety tube
Number of subjects: 200
Study 32508977 — intervention group
Group type: COMPARATOR
Intervention: Conventional infusion needles
Number of subjects: 200
Study 32508977 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 34928192 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical hypnosis
Number of subjects: 40
Study 34928192 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 32197911 — intervention group
Group type: EXPERIMENTAL
Intervention: Tian‐Tian 120 outdoor program (120 minutes outdoors daily)
Number of subjects: 1200000
Study 32197911 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention period (2001-2011)
Number of subjects: 1200000
Study 32197911 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention trend analysis
Number of subjects: 1200000
Study 32197911 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention trend analysis
Number of subjects: 1200000
Study 35789065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic-activated irrigation (UI)
Number of subjects: 42
Study 35789065 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser (LI)
Number of subjects: 42
Study 35789065 — intervention group
Group type: COMPARATOR
Intervention: Manual irrigation (Control)
Number of subjects: 42
Study 35789065 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant subgroups (2.5% NaOCl irrigant and ChlorCid™️ Surf)
Number of subjects: 42
Study 33720069 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab added to first-line chemotherapy
Number of subjects: 0
Study 33720069 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab added to first-line chemotherapy
Number of subjects: 0
Study 33720069 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant nivolumab
Number of subjects: 0
Study 33720069 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab and trastuzumab added to perioperative FLOT
Number of subjects: 0
Study 33720069 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Number of subjects: 0
Study 32914653 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE)
Number of subjects: 0
Study 32914653 — intervention group
Group type: COMPARATOR
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0
Study 35149701 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (300 mg oral) and Methylprednisolone (125 mg IV)
Number of subjects: 160
Study 35149701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 33556153 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention model
Number of subjects: 12
Study 34935050 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered electrotherapy treatment using the Exopulse Mollii Suit®
Number of subjects: 15
Study 34863272 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-magnitude high-frequency vibration (LMHFV)
Number of subjects: 0
Study 34863272 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 34863272 — intervention group
Group type: EXPERIMENTAL
Intervention: LMHFV
Number of subjects: 0
Study 36327101 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil once a day (QD)
Number of subjects: 40
Study 36327101 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil twice a day (BID)
Number of subjects: 40
Study 32595142 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mL 0.25% ropivacaine divided into four injections (two for TAP and two for RS block)
Number of subjects: 150
Study 32595142 — intervention group
Group type: COMPARATOR
Intervention: Normal saline in the same manner as the intervention group
Number of subjects: 150
Study 34398206 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowered relief
Number of subjects: 263
Study 34398206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 263
Study 34398206 — intervention group
Group type: COMPARATOR
Intervention: Health Education
Number of subjects: 263
Study 32500519 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight and revealing athletic clothing (TR group)
Number of subjects: 80
Study 32500519 — intervention group
Group type: COMPARATOR
Intervention: Loose and concealing athletic clothing (LC group)
Number of subjects: 80
Study 36286602 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray (ZNS) high dose
Number of subjects: 373
Study 36286602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 373
Study 33388411 — intervention group
Group type: EXPERIMENTAL
Intervention: Ring on anastomosis (ROA)
Number of subjects: 119
Study 33388411 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 119
Study 32090389 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR), 8-week program, n=15
Number of subjects: 28
Study 32090389 — intervention group
Group type: COMPARATOR
Intervention: Support group with relaxation education materials, n=13
Number of subjects: 28
Study 35306189 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive virtual reality (VR) play intervention including instructional play and emotional catharsis play sessions
Number of subjects: 134